Axel Capital Management, LLC Abb Vie Inc. Transaction History

Axel Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$137.62 - $174.96 $8.12 Million - $10.3 Million	-59,000 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$131.98 - $163.75 $5.54 Million - $6.88 Million	42,000 Added 247.06%	59,000 $9.56 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $1.83 Million - $2.31 Million	17,000 New	17,000 $2.3 Million
Q1 2021 May 10, 2021	SELL	$102.3 - $112.62 $265,775 - $292,586	-2,598 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $190,615 - $255,071	2,598 New	2,598 $255,000

3,650

1.24B

15.5M

11.5M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $305B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Axel Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Axel Capital Management, LLC with notifications on news.